Alexander J M Foulkes
Overview
    Explore the profile of Alexander J M Foulkes including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              16
            
            
              Citations
              860
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Hallqvist J, Pinto R, Heywood W, Cordey J, Foulkes A, Slattery C, et al.
  
  
    Int J Mol Sci
    . 2023 Sep;
          24(18).
    
    PMID: 37762058
  
  
          As disease-modifying therapies are now available for Alzheimer's disease (AD), accessible, accurate and affordable biomarkers to support diagnosis are urgently needed. We sought to develop a mass spectrometry-based urine test...
      
2.
        
    
    Khoo A, Jaunmuktane Z, Foulkes A
  
  
    Intern Med J
    . 2022 Jan;
          52(1):152-154.
    
    PMID: 35060280
  
  
          No abstract available.
      
3.
        
    
    Veale T, Malone I, Poole T, Parker T, Slattery C, Paterson R, et al.
  
  
    Brain Commun
    . 2021 Dec;
          3(4):fcab272.
    
    PMID: 34859218
  
  
          Pathological cerebral white matter changes in Alzheimer's disease have been shown using diffusion tensor imaging. Superficial white matter changes are relatively understudied despite their importance in cortico-cortical connections. Measuring superficial...
      
4.
        
    
    Paterson R, Brown R, Vivekanandam V, Foulkes A, Thom M, Wiethoff S, et al.
  
  
    Brain
    . 2020 Dec;
          143(12):e101.
    
    PMID: 33324968
  
  
          No abstract available.
      
5.
        
    
    Paterson R, Brown R, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al.
  
  
    Brain
    . 2020 Jul;
          143(10):3104-3120.
    
    PMID: 32637987
  
  
          Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness. Responding to this, a weekly virtual coronavirus disease 19 (COVID-19)...
      
6.
        
    
    Canas L, Sudre C, De Vita E, Nihat A, Mok T, Slattery C, et al.
  
  
    Neuroimage Clin
    . 2019 Nov;
          24:102051.
    
    PMID: 31734530
  
  
          Prion diseases are a group of rare neurodegenerative conditions characterised by a high rate of progression and highly heterogeneous phenotypes. Whilst the most common form of prion disease occurs sporadically...
      
7.
        
    
    Firth N, Primativo S, Marinescu R, Shakespeare T, Suarez-Gonzalez A, Lehmann M, et al.
  
  
    Brain
    . 2019 Jun;
          142(7):2082-2095.
    
    PMID: 31219516
  
  
          Posterior cortical atrophy is a clinico-radiological syndrome characterized by progressive decline in visual processing and atrophy of posterior brain regions. With the majority of cases attributable to Alzheimer's disease and...
      
8.
        
    
    Slattery C, Agustus J, Paterson R, McCallion O, Foulkes A, Macpherson K, et al.
  
  
    Cortex
    . 2019 Mar;
          115:357-370.
    
    PMID: 30846199
  
  
          Background: Memory for music has attracted much recent interest in Alzheimer's disease but the underlying brain mechanisms have not been defined in patients directly. Here we addressed this issue in...
      
9.
        
    
    Parker T, Slattery C, Yong K, Nicholas J, Paterson R, Foulkes A, et al.
  
  
    Neuroimage Clin
    . 2018 Dec;
          21:101632.
    
    PMID: 30558867
  
  
          The most common presentation of early onset Alzheimer's disease (EOAD - defined as symptom onset <65 years) is with progressive episodic memory impairment - amnestic or typical Alzheimer's disease (tAD)....
      
10.
        
    
    Yong K, McCarthy I, Poole T, Suzuki T, Yang B, Carton A, et al.
  
  
    Ann Clin Transl Neurol
    . 2018 Jun;
          5(6):697-709.
    
    PMID: 29928653
  
  
          Objective: Deficits in spatial navigation are characteristic and disabling features of typical Alzheimer's disease (tAD) and posterior cortical atrophy (PCA). Visual cues have been proposed to mitigate such deficits; however,...